KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,398,000 | -54.5% | 155,603 | -47.5% | 0.15% | -65.3% |
| Q4 2020 | $9,675,000 | +40.0% | 296,203 | +31.3% | 0.43% | -14.8% |
| Q3 2020 | $6,910,000 | -31.1% | 225,603 | -63.4% | 0.50% | -37.4% |
| Q2 2020 | $10,035,000 | +32.7% | 615,619 | -19.0% | 0.80% | +40.4% |
| Q1 2020 | $7,560,000 | – | 759,803 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |